BridgeBio Oncology Therapeutics, Inc. (BBOT): 8-K filed Jun 22, 2026

Form type
8-K
Filing date
Jun 22, 2026
Accession number
0001193125-26-277513
Filer
BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)